Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
85.00
-1.39 (-1.61%)
At close: Oct 30, 2026, 4:00 PM EDT
86.00
+1.00 (1.18%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $5.52 billion as of October 30, 2026. It is the 3,318th most valuable company in the world and the 1,083rd biggest in the United States. Its market cap has increased by 55.92% in one year.
Market Cap
5.52B
Enterprise Value
5.84B
1-Year Change
55.92%
Global Rank
Country Rank
#1,083 United States
Category
ChartMarket Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $5.52B, an increase of 1,756.91%. That is a compound annual growth rate of 49.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 5.52B | 35.19% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 6.23B |
| Immunovant | 6.09B |
| Belite Bio | 6.08B |
| Veradermics | 6.00B |
| CG Oncology | 5.61B |
| Cogent Biosciences | 5.54B |
| Scholar Rock Holding | 5.40B |
| PTC Therapeutics | 5.34B |